Cow's Milk Protein Allergy Clinical Trial
Official title:
A Double-blind, Randomised-controlled Trial Evaluating a Hydrolysed Rice Formula Compared to a Cow's Milk Protein-based Extensively Hydrolysed Formula in Infants With Cow's Milk Allergy
This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04596059 -
The Journey of Children With Cow's Milk Protein Allergy in Mexico.
|
||
| Not yet recruiting |
NCT06130085 -
Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination
|
N/A | |
| Completed |
NCT03769051 -
Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
|
||
| Completed |
NCT02953223 -
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
|
||
| Completed |
NCT03085134 -
Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides
|
N/A | |
| Completed |
NCT06273371 -
Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain
|